|
BIND Therapeutics Announces Closing of Public Offering of Common Stock and …
Business Wire (press release) CAMBRIDGE, Mass.–(BUSINESS WIRE)–BIND Therapeutics, Inc. (NASDAQ:BIND), a clinical-stage nanomedicine platform company developing targeted and programmable therapeutics called Accurins™, today announced the closing of its previously … 8-K Filing Shows Bind Therapeutics Closes Offering Of StockBenzinga |
